Organogenesis Inc. (ORGO)
NASDAQ: ORGO
· Real-Time Price · USD
2.72
-0.02 (-0.73%)
At close: Jun 02, 2025, 1:13 PM
-0.73% (1D)
Bid | 2.71 |
Market Cap | 345.04M |
Revenue (ttm) | 458.76M |
Net Income (ttm) | -18.63M |
EPS (ttm) | -0.16 |
PE Ratio (ttm) | -17 |
Forward PE | 19.03 |
Analyst | Hold |
Ask | 2.72 |
Volume | 704,738 |
Avg. Volume (20D) | 1,595,653 |
Open | 2.78 |
Previous Close | 2.74 |
Day's Range | 2.70 - 2.83 |
52-Week Range | 2.28 - 6.71 |
Beta | 1.85 |
About ORGO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ORGO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ORGO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-42.7%
Organogenesis Holdings shares are trading lower af...
Unlock content with
Pro Subscription
2 months ago
+19.25%
Organogenesis shares are trading higher after Morgan Stanley raised its price on the stock from $4 to $6.

3 weeks ago · seekingalpha.com
Organogenesis Holdings Inc. (ORGO) Q1 2025 Earnings Call TranscriptOrganogenesis Holdings Inc. (NASDAQ:ORGO ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Gary Gillheeney - President and Chief Executive Officer David Francisco - Chief ...